European Commission logo
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-21

Development of neuroprotective leadstructures derived from neuropeptid qynad

Objective

Genopia Biomedical GmbH is a European biotechnology company focused on -Drug Development and Target Discovery -Protein Interaction Screening -Rational Designed Protein BioChips We are currently offering two fellow positions/looking for two individuals (1 postgraduate, 1 postdoc) with background in protein-chemistry and hands-on experience in one or more of following techniques: 2D-electrophoresis, mass spectrometry, functional characterization of proteins, pull-down-assays and immuno- precipitation, protein biochip technologies. In close cooperation with our R&D partner institution at the University of Ulm the candidates will be involved in cutting-edge research with world leading experts in neurophysiology in area of multiple sclerosis and ion channel research. Their task will be the investigation of neuroprotective peptides: Identification of target proteins; Isolation of precursorpeptide; Screening of a peptide library; Electrophysiological testing of peptides. Genopia will offer the fellows active support during their stay and the experienced research group at the University of Ulm will provide a sound scientific basis.

Topic(s)

Data not available

Call for proposal

Data not available

Coordinator

GENOPIA BIOMEDICAL GMBH
EU contribution
No data
Address
Albert-Einstein-Allee 11
89069 ULM
Germany

See on map

Total cost
No data